298. 遺伝性膵炎 Hereditary pancreatitis Clinical trials / Disease details
臨床試験数 : 98 / 薬物数 : 180 - (DrugBank : 57) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02947087 (ClinicalTrials.gov) | October 2016 | 18/10/2016 | Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis | Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival | Chronic Pancreatitis | Drug: Prolastin-C;Drug: Placebo | Medical University of South Carolina | NULL | Active, not recruiting | 18 Years | N/A | All | 48 | Phase 1/Phase 2 | United States |